BioSpace News Archive

Crizanlizumab is a monthly infusion under development to prevent pain crises (also called vaso-occlusive crises, or VOCs) in patients with sickle cell disease

Innovative technology facilitates care management and collaboration among behavioral, medical, and social service provider organizations for homeless Medi-Cal beneficiaries.

Canopy Growth Corporation once again applauds the passage of the U.S. 2018 Farm Bill.

Founded in 2007, HHA offers a comprehensive Software-as-a-Service platform to its customers that improves patient outcomes, drives operational efficiency and increases compliance.

Fortune recognition among additional accolades from Deloitte, PM360, and Pharmaceutical Manufacturing for continued growth and innovation

A concerned Texas mom finally has answers about the cause of her son’s sensory-processing problems thanks to a special collaboration among her patient-advocacy group and the lab of Scripps Research Neuroscientist Gavin Rumbaugh, PhD.

Ceramedx® Is Changing the Direction of Healthy Skin Care

Company granted broad and exclusive patent rights for the use of an epigenetic biomarker as a diagnostic tool for cancer.

Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.

CannTrust Holdings Inc. (“CannTrust” or the “Company”, TSX: TRST), one of Canada’s leading, most trusted licensed producers of cannabis and the 2018 Canadian Cannabis Awards “Top Licensed Producer of the Year”, announces that it has applied to list its common shares on the New York Stock Exchange (the “NYSE”).